Birds Eye View Technical Analysis forBioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) for the period of 9-Day stands at 35.16% while the stochastic %D for the same period stands at 37.45%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indicator of a certain security, currently BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)’s 20-Day Bollinger Band indicates “Sell”.

About Company

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.

Previous Day Activity Analysis

On the last trading day, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) opened the session at $5.18 and after going down -2.7% closed at $5.05. The stock lost -0.13 points in the last trade.

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)’s stock fluctuated in the range of $4.93 and $5.18 during the previous active session. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) traded with the volume of 1.33 Million with average volume of 1.53 Million. The stock has LOW volatility on the last trading session.

Currently the Beta for the company remains at 3.23 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.26 and 46.76 respectively.

Currently the Insider Ownership of the shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is at 0.4% and the shares outstanding are 82.69 Million.

Important Ratio Analysis

Some important ratios to consider here for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) are discussed below:

Dividend yield of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The PEG ratio (Price to Earning to Growth) emits the value of 0. The Price to Sale P/S and Price to Book P/B shows the value of 14.25 and 16.83 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 5.17 and 0 correspondingly.

The Quick Ratio of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands at 1.5 while the Current Ratio depicts the value of 1.6.

Return on Assets ROA of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is at -44.4% whereas, Return on Equity ROE and Return of Investment ROI of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stand at -276.6% and -87.9% respectively.

Stock Performance Analysis

The stock performance of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) on the basis of 5 day trade show the dip of -3.44% whereas, the monthly performance of the stock shows decrease of -1.94%.

The quarterly performance of the stock remained in red zone with the value of -10.93% while six month performance of the shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) remained bearish with the count of -27.44%.

The yearly and YTD performance of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) remained mix at 21.39% and -20.22% respectively.